Evidence map›Paper›PMID 35490691›Full record

Trial reportLancet (London, England)2022

Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label, nationwide, stepped-wedge cluster-randomised trial.

F Jasmijn Smits, Anne Claire Henry, Marc G Besselink, Olivier R Busch, Casper H van Eijck, Mark Arntz, Thomas L Bollen, Otto M van Delden, Daniel van den Heuvel, Christiaan van der Leij and 34 more

Open access · bronzeAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Lancet (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 5 pooled it
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 5 syntheses or guidelines pooled it, 161 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. International Society for Diseases of the Esophagus consensus on the diagnosis and treatment of anastomotic leak after esophagectomy.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2026
    Guideline
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 1 country.

F Jasmijn SmitsDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Anne Claire HenryDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Marc G BesselinkDepartment of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Olivier R BuschDepartment of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Casper H van EijckDepartment of Surgery, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Mark ArntzDepartment of Radiology, Radboud University Medical Centre, Nijmegen, Netherlands.
Thomas L BollenDepartment of Radiology, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Otto M van DeldenDepartment of Radiology, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Daniel van den HeuvelDepartment of Radiology, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Christiaan van der LeijDepartment of Radiology, Maastricht University Medical Centre, Maastricht, Netherlands.
Krijn P van LiendenDepartment of Radiology, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Adriaan MoelkerDepartment of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Bert A BonsingDepartment of Surgery, Leiden University Medical Centre, Leiden, Netherlands.
Inne H Borel RinkesDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Koop BosschaDepartment of Surgery, Jeroen Bosch Hospital, Den Bosch, Netherlands.
Ronald M van DamDepartment of Surgery, Maastricht University Medical Centre, Maastricht, Netherlands.
Wouter J M DerksenDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Marcel den DulkDepartment of Surgery, Maastricht University Medical Centre, Maastricht, Netherlands.
Sebastiaan FestenDepartment of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands.
Bas Groot KoerkampDepartment of Surgery, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Robbert J de HaasDepartment of Radiology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Jeroen HagendoornDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Erwin van der HarstDepartment of Surgery, Maasstad Hospital, Rotterdam, Netherlands.
Ignace H de HinghDepartment of Surgery, Catharina Hospital, Eindhoven and GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.
Geert KazemierDepartment of Surgery, Cancer Centre Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Marion van der KolkDepartment of Surgery, Radboud University Medical Centre, Nijmegen, Netherlands.
Mike LiemDepartment of Surgery, Medisch Spectrum Twente, Enschede, Netherlands.
Daan J LipsDepartment of Surgery, Medisch Spectrum Twente, Enschede, Netherlands.
Misha D LuyerDepartment of Surgery, Catharina Hospital, Eindhoven and GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands.
Vincent E de MeijerDepartment of Surgery, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
J Sven MieogDepartment of Surgery, Leiden University Medical Centre, Leiden, Netherlands.
Vincent B NieuwenhuijsDepartment of Surgery, Isala, Zwolle, Netherlands.
Gijs A PatijnDepartment of Surgery, Isala, Zwolle, Netherlands.
Wouter W Te RieleDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Daphne RoosDepartment of Surgery, Reinier de Graaf Hospital, Delft, Netherlands.
Jennifer M SchreinemakersDepartment of Surgery, Amphia Hospital, Breda, Netherlands.
Martijn W J StommelDepartment of Surgery, Radboud University Medical Centre, Nijmegen, Netherlands.
Fennie WitDepartment of Surgery, Tjongerschans Hospital, Heerenveen, Netherlands.
Babs A ZonderhuisDepartment of Surgery, Cancer Centre Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Lois A DaamenDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
C Henri van WerkhovenJulius Centre for Health Sciences and Primary Care, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
I Quintus MolenaarDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands.
Hjalmar C van SantvoortDepartment of Surgery, Regional Academic Cancer Centre Utrecht, St Antonius Hospital, Nieuwegein and University Medical Centre Utrecht, Utrecht, Netherlands. Electronic address: h.vansantvoort@umcutrecht.nl.
Dutch Pancreatic Cancer Group
St. Antonius Ziekenhuis · NLUniversity Medical Center Utrecht · NLAmsterdam University Medical Centers · NLErasmus MC Cancer Institute · NLMaastricht University Medical Centre · NLIsala · NLLeiden University Medical Center · NLMedisch Spectrum Twente · NLRadboud University Medical Center · NLRadboud University Nijmegen · NLVrije Universiteit Amsterdam · NLAmphia Ziekenhuis · NLJeroen Bosch Ziekenhuis · NLMaasstad Ziekenhuis · NLMaastricht University · NLOLVG · NLReinier de Graaf Hospital · NL's Heeren Loo · NLUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly recognition and management of postoperative complications, before they become clinically relevant, can improve postoperative outcomes for patients, especially for high-risk procedures such as pancreatic resection.

methodsWe did an open-label, nationwide, stepped-wedge cluster-randomised trial that included all patients having pancreatic resection during a 22-month period in the Netherlands. In this trial design, all 17 centres that did pancreatic surgery were randomly allocated for the timing of the crossover from usual care (the control group) to treatment given in accordance with a multimodal, multidisciplinary algorithm for the early recognition and minimally invasive management of postoperative complications (the intervention group). Randomisation was done by an independent statistician using a computer-generated scheme, stratified to ensure that low-medium-volume centres alternated with high-volume centres. Patients and investigators were not masked to treatment. A smartphone app was designed that incorporated the algorithm and included the daily evaluation of clinical and biochemical markers. The algorithm determined when to do abdominal CT, radiological drainage, start antibiotic treatment, and remove abdominal drains. After crossover, clinicians were trained in how to use the algorithm during a 4-week wash-in period; analyses comparing outcomes between the control group and the intervention group included all patients other than those having pancreatic resection during this wash-in period. The primary outcome was a composite of bleeding that required invasive intervention, organ failure, and 90-day mortality, and was assessed by a masked adjudication committee. This trial was registered in the Netherlands Trial Register, NL6671.

findingsFrom Jan 8, 2018, to Nov 9, 2019, all 1805 patients who had pancreatic resection in the Netherlands were eligible for and included in this study. 57 patients who underwent resection during the wash-in phase were excluded from the primary analysis. 1748 patients (885 receiving usual care and 863 receiving algorithm-centred care) were included. The primary outcome occurred in fewer patients in the algorithm-centred care group than in the usual care group (73 [8%] of 863 patients vs 124 [14%] of 885 patients; adjusted risk ratio [RR] 0·48, 95% CI 0·38-0·61; p<0·0001). Among patients treated according to the algorithm, compared with patients who received usual care there was a decrease in bleeding that required intervention (47 [5%] patients vs 51 [6%] patients; RR 0·65, 0·42-0·99; p=0·046), organ failure (39 [5%] patients vs 92 [10%] patients; 0·35, 0·20-0·60; p=0·0001), and 90-day mortality (23 [3%] patients vs 44 [5%] patients; 0·42, 0·19-0·92; p=0·029).

interpretationThe algorithm for the early recognition and minimally invasive management of complications after pancreatic resection considerably improved clinical outcomes compared with usual care. This difference included an approximate 50% reduction in mortality at 90 days.

fundingThe Dutch Cancer Society and UMC Utrecht.

Indexed as

DrainagePancreatectomyAlgorithmsHemorrhageHumansNetherlandsPostoperative ComplicationsTreatment Outcome

Identifiers

PMID35490691
OpenAlexW4225103162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.